Abiopharma

🔍 SUSSMAN ELLIOT J MD MBA (Director)

Company: UNIVERSAL HEALTH SERVICES INC (UHS)

Report Date: 2025-10-29

Detailed Transactions and Holdings:

• Acquired 2,500 shares of Class B Common Stock at $138.8 per share (Direct)
  Date: 2025-10-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,613.00 | transaction_form_type: 4
• Sold 1,535 shares of Class B Common Stock at $226.15 per share (Direct)
  Date: 2025-10-29 | Code: F | equity_swap_involved: 0 | shares_owned_after: 7,078.00 | transaction_form_type: 4
• Sold 965 shares of Class B Common Stock at $225.6981 per share (Direct)
  Date: 2025-10-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,113.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,500 shares of Option To Purchase Class B Common Stock at $138.8 per share (Derivative)
  Date: 2025-10-29 | Code: M | Expires: 2026-03-16 | equity_swap_involved: 0 | shares_owned_after: 2,500.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.38 to $225.80, inclusive. The reporting person undertakes to provide Universal Health Services, Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 1.
• F2: Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.